U.S. Stem Cell, Inc. Annual Operating Margin in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
U.S. Stem Cell, Inc. quarterly/annual Operating Margin history and growth rate from 2017 to 2022.
  • U.S. Stem Cell, Inc. Operating Margin for the quarter ending December 31, 2022 was -2.1K %, a 97.1% decline year-over-year.
  • U.S. Stem Cell, Inc. annual Operating Margin for 2022 was -2.1K %, a 97.1% decline from 2021.
  • U.S. Stem Cell, Inc. annual Operating Margin for 2021 was -1.06K %, a 22.8% decline from 2020.
  • U.S. Stem Cell, Inc. annual Operating Margin for 2020 was -866 %, a 679% decline from 2019.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -2.1K -1.03K -97.1% Jan 1, 2022 Dec 31, 2022
2021 -1.06K -198 -22.8% Jan 1, 2021 Dec 31, 2021
2020 -866 -755 -679% Jan 1, 2020 Dec 31, 2020
2019 -111 -94.8 -579% Jan 1, 2019 Dec 31, 2019
2018 -16.4 -1.81 -12.4% Jan 1, 2018 Dec 31, 2018
2017 -14.6 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.